Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: J Neurooncol. 2022 Feb 25;157(1):187–195. doi: 10.1007/s11060-022-03961-5

Table 4.

Univariable Cox proportional hazards models of overall survival by molecular marker

Molecular marker HR 95% CI (p-value)
Loss of CDKN2A/B 0.58 (0.15, 2.35) 0.499
EGFR amplification 0.50 (0.112, 2.06) 0.399
TERT promoter mutation N/A N/A N/A
+ 7/− 10 1.08 (0. 27, 4.36) 0.910
PTEN mutation 1.09 (0.13, 8.97) 0.937
Chromosome 9 abnormalities 0.94 (0.19, 4.68) 0.942